HBAN CEO Steinour buys 32,277 shares at $15.49; stock now $15.28 vs $19.27 52-week high.
CEO Stephen D Steinour purchased 32,277 shares of Huntington Bancshares at $15.49 on March 12, 2026, adding to a 1.44M share post-transaction position. The purchase occurred after a significant pullback: the stock is -20.7% from its 52-week high of $19.27 and down -11.5% over 30 days. Huntington's fundamentals remain solid with a P/E of 12.42 and annual revenue growth of +6.4%, supporting a $31.0B market cap. Steinour's prior open-market purchase across all tickers generated a 100.00% 90-day win rate with +13.8% average return, establishing a track record of favorable outcome timing. This buy by the top executive at depressed valuation relative to recent trading range represents material accumulation in his own company during a period of stock weakness.
Director Stephen D. Steinour bought 6,700 BBWI shares at $14.86; 5 other insiders bought within 14 days amid -62.1% 52-week decline.
Stephen D. Steinour, a director at Bath & Body Works, purchased 6,700 shares at $14.86 on 2025-11-21, increasing his holdings to 48,175 shares from 41,475 shares (+16.2% net change). This transaction occurs within a cluster pattern: 5 other insiders have also bought within the past 14 days. The timing is notable given that the stock trades at $15.56 currently, down -62.1% from its 52-week high of $41.08, with a steep -50.4% 90-day decline. The company's fundamentals show a P/E of 4.56 and annual revenue decline of -1.6%, though it generated $1.6B in quarterly revenue and $77.0M in net income. The coordinated buying activity among multiple insiders at depressed price levels merits examination as a potential indicator of management's assessment of valuation.
